IP Library Granted Patent US 7,131,988
Granted Patent B2
US 7,131,988 · App. 10/801,315 · Granted Nov 7, 2006

Reforming wet-tantalum capacitors in implantable medical devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,131,988
App. No.
10/801,315
Granted
Nov 7, 2006
Kind
B2
Abstract

Miniature defibrillators and cardioverters detect abnormal heart rhythms and automatically apply electrical therapy to restore normal heart function. Critical to this function, aluminum-electrolytic capacitors store and deliver life-saving bursts of electric charge to the heart. This type of capacitor requires regular “reform” to preserve its charging efficiency over time. Because reform expends valuable battery energy, manufacturers developed wet-tantalum capacitors, which are generally understood not to require reform. Yet, the present inventors discovered through extensive study that wet-tantalum capacitors exhibit progressively worse charging efficiency over time. Accordingly, to address this problem, the inventors devised unique reform techniques for wet-tantalum capacitors. One exemplary technique entails charging wet-tantalum capacitors to a voltage equal to about 90% of their rated voltage and allowing the charge to dissipate through system leakage for a period of time, before discharging through a non-therapeutic load.

Claims (30)

1. A capacitor-reform method comprising:

a) charging at least one wet-tantalum capacitor in an implantable medical device;

b) allowing the one wet-tantalum capacitors to discharge through system leakage after charging the one wet-tantalum capacitor in the implantable medical device; and

c) discharging the one or more of the wet-tantalum capacitors through a non-therapeutic load, after allowing the one or more wet-tantalum capacitors to discharge through system leakage.

2. The method of claim 1 , wherein the implantable medical device has a housing and the non-therapeutic load is a resistor within the housing.

3. The method of claim 1 , wherein the one wet-tantalum capacitor comprises a tantalum anode and a non-tantalum cathode.

4. The method of claim 1 , wherein the implantable device includes means for defibrillation, means for cardioversion, or means for pacemaking.

5. A capacitor-reform method comprising:

a) charging at least one wet-tantalum capacitor to a high voltage relative its rated voltage or maximum-energy voltage;

b) partially discharging the one the wet-tantalum capacitors through system leakage after charging the one wet-tantalum capacitor to the high voltage; and

c) discharging the one or more of the wet-tantalum capacitors through a non-therapeutic load, after partially discharging the one or more wet-tantalum capacitors through system leakage.

6. The method of claim 5 , wherein the high voltage is about 90 percent of the rated voltage or a maximum-energy voltage for the capacitor.

7. The method of claim 5 , wherein the implantable medical device has a housing and the non-therapeutic load is a resistor within the housing.

8. The method of claim 5 , wherein the one wet-tantalum capacitor comprises a tantalum anode and a non-tantalum cathode.

9. The method of claim 5 , wherein the partial discharging is initiated after a time period of at least 60 seconds.

10. The method of claim 5 , wherein the implantable device includes means for defibrillation, means for cardioversion, or means for pacemaking.

11. A capacitor-reform method comprising:

a) charging at least one wet-tantalum capacitor in an implantable medical device, in response to a reform signal from a processor in the medical device;

b) allowing the one wet-tantalum capacitors to discharge through system leakage after charging the one wet-tantalum capacitor in the implantable medical device; and

c) discharging the one or more of the wet-tantalum capacitors through a non-therapeutic load, after allowing the one or more wet-tantalum capacitors to discharge through system leakage.

12. The method of claim 11 , wherein the implantable medical device has a housing and the non-therapeutic load is a resistor within the housing.

13. The method of claim 11 , wherein the one wet-tantalum capacitor comprises a tantalum anode and a non-tantalum cathode.

14. The method of claim 11 , wherein the implantable device includes means for defibrillation, means for cardioversion, or means for pacemaking.

15. A capacitor-reform method comprising:

a) charging at least one wet-tantalum capacitor in a device to a voltage;

b) allowing the one wet-tantalum capacitors to discharge through system leakage after charging the one wet-tantalum capacitor in the device; and

c) discharging the one or more of the wet-tantalum capacitors through a load, after allowing the one or more wet-tantalum capacitors to discharge through system leakage.

16. The method of claim 15 , wherein the device has a housing and the load is a resistor within the housing.

17. The method of claim 15 , wherein the one wet-tantalum capacitor comprises a tantalum anode and a non-tantalum cathode.

18. The method of claim 15 , wherein the device is implantable and includes a housing and at least one of means for defibrillation, means for cardioversion, and means for pacemaking; and wherein the load includes a resistor within the housing.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Oct 12, 2022
From: MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT)
To: GREATBATCH, INC.; GREATBATCH LTD.; ELECTROCHEM SOLUTIONS, INC.; NEURONEXUS TECHNOLOGIES, INC.; GREATBATCH-GLOBE TOOL, INC.; PRECIMED INC.; MICRO POWER ELECTRONICS, INC.
Reel/Frame 061659/0858 →
RELEASE OF SECURITY INTEREST Recorded Jan 6, 2022
From: MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT)
To: GREATBATCH, INC.; GREATBATCH LTD.; ELECTROCHEM SOLUTIONS, INC.; NEURONEXUS TECHNOLOGIES, INC.; GREATBATCH-GLOBE TOOL, INC.; PRECIMED INC.; MICRO POWER ELECTRONICS, INC.
Reel/Frame 060938/0069 →
RELEASE OF SECURITY INTEREST Recorded Jan 6, 2022
From: MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT)
To: GREATBATCH LTD.
Reel/Frame 058574/0437 →
SECURITY INTEREST Recorded Sep 10, 2021
From: GREATBATCH LTD.; ELECTROCHEM SOLUTIONS, INC.; LAKE REGION MEDICAL, INC.; LAKE REGION MANUFACTURING, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 057468/0056 →
SECURITY INTEREST Recorded Oct 27, 2015
From: GREATBATCH, INC.; GREATBATCH LTD.; ELECTROCHEM SOLUTIONS, INC.; NEURONEXUS TECHNOLOGIES, INC.; GREATBATCH-GLOBE TOOL, INC.; PRECIMED INC.; MICRO POWER ELECTRONICS, INC.
To: MANUFACTURERS AND TRADERS TRUST COMPANY
Reel/Frame 036980/0482 →
SECURITY INTEREST Recorded Nov 22, 2007
From: GREATBATCH LTD.
To: MANUFACTURERS AND TRADERS TRUST COMPANY
Reel/Frame 020571/0205 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2007
From: WILSON GREATBATCH TECHNOLOGIES, INC.
To: GREATBATCH, LTD. (NEW YORK CORPORATION)
Reel/Frame 019668/0811 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2004
From: CARDIAC PACEMAKERS, INC.
To: WILSON GREATBATCH TECHNOLOGIES, INC.
Reel/Frame 015232/0587 →